Cell And Gene Therapy Videos

  1. Integrated Technologies And Glycosylation Tuning In Upstream Bioprocessing 7/1/2025

    Optimize mAb production with innovative cell culture media and feed designs. Explore integrated technologies, intensified fed-batch approaches, and methods to modulate glycosylation profiles in upstream bioprocessing.

  2. The World Outside Influencing Your Outsourcing Internals 6/26/2025

    Tariffs, geopolitical gyrations, (pending) laws such as the BIOSECURE Act; all affect your outsourcing optionality and decision-making. Our panel of internationally savvy biopharma executives provide some guiding insights.

  3. Your CDMO Knows A Lot - Are You Listening? 6/26/2025

    Our three experienced panelists weigh in on how sponsors should take advantage of what CDMOs know from experience in quality, regulatory, and other aspects of development and processing.

  4. CDMO SOWs Must (Re-)Align With New Project Realities 6/26/2025

    Decades of experience in cell and gene therapy outsourcing have taught Donna Rill, Chief Technology Officer, Triumvira Immunologics, that the key to success is ensuring CDMOs and sponsors understand the need to continuously align SOWs with the variances as projects move forward.

  5. Budgeting Key Component In Biologics Flexibility At CDMOs 6/26/2025

    You want flexibility in scheduling, contracts, and the entire CDMO relationship. While money can't buy you love, it can go a long way in getting that more flexible partnership.

  6. An Intro To CDMO Flexibility 6/26/2025

    Seshu Tummala, Executive Director at Uniquity Bio discusses some of the components of "CDMO flexibility" when it comes to biologics outsourcing relationships.

  7. Outsourcing Biologics Comes With "Demands" 6/26/2025

    Chief Editor Louis Garguilo opens the discussion with our panelists on the state of biologics outsourcing, and the "must haves" for sponsors of their CDMOs.

  8. Where CDMOs Can Improve For CGT Customers? 6/26/2025

    Donna Rill, Chief Technology Officer, Triumvira Immunologics, has advice for CDMOs to improve their service to CGT customers, and conversely, where drug developers can improve as well.

  9. Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot Scale 6/26/2025

    Discover a systematic approach to scalable plasmid DNA production using E. coli OneShot Top10, which features DOE-driven optimization and key insights for efficient biomanufacturing success.

  10. Navigating The Complex Landscape Of Lentiviral Vector Quality Control 6/26/2025

    Explore the latest in lentiviral vector release testing, which covers biosafety, regulatory insights, and QC strategies to ensure patient safety and accelerate your path to clinic.